Sign Up to like & get
recommendations!
0
Published in 2021 at "British journal of cancer"
DOI: 10.1038/s41416-021-01522-7
Abstract: BACKGROUND Individualising treatment in breast cancer requires effective predictive biomarkers. While relatively few genomic aberrations are clinically relevant, there is a need for characterising patients across different subtypes to identify actionable alterations. METHODS We identified…
read more here.
Keywords:
actionable alterations;
putative actionable;
breast cancer;
clinically relevant ... See more keywords